Table 1.
Characteristics of the individuals included in the pooled database (n = 1738).
| Hemi-/Homozygous * | Compound Heterozygous | Heterozygous * | |
|---|---|---|---|
| Sex | |||
| Female | 150 (8.6) | 20 (1.2) | 1012 (58.2) |
| Male | 556 (31.9) | - | - |
| Age | |||
| Mean (range) | 23.8 (1.0–78.0) | 23.2 (1.0–40.0) | 26.4 (1.0–75.0) |
| Country | |||
| Bangladesh | 94 (5.4) | - | 50 (2.9) |
| Brazil | 2 (0.1) | - | 0 (0.0) |
| Cambodia | 125 (7.2) | - | 66 (3.8) |
| China | 113 (6.5) | 12 (0.7) | 117 (6.7) |
| Indonesia | 78 (4.5) | 2 (0.1) | 273 (15.7) |
| Myanmar | 66 (3.8) | - | 66 (3.8) |
| Palestine | 64 (3.7) | - | 4 (0.2) |
| Thailand | 82 (4.7) | 5 (0.3) | 290 (16.7) |
| Uganda | 58 (3.3) | - | 79 (4.5) |
| USA | 24 (1.4) | 1 (0.1) | 67 (3.9) |
| Spectrophotometry Assay | |||
| Pointe Scientific | 7 (0.4) | - | 14 (0.8) |
| Randox | 194 (11.2) | - | 105 (6.0) |
| Trinity | 352 (20.3) | 4 (0.2) | 544 (31.3) |
| WHO Method | 40 (2.3) | 4 (0.2) | 232 (13.3) |
| Zhongshan Biotech | 113 (6.5) | 12 (0.7) | 117 (6.7) |
| Genotyping Assay | |||
| PCR | 374 (21.5) | 18 (1.0) | 742 (42.7) |
| Sequencing | 332 (19.1) | 2 (0.1) | 270 (15.5) |
| Total | 706 (40.6) | 20 (1.2) | 1012 (58.2) |
* Unless otherwise indicated, values represent n (%) of the total database in each category.